Below are the most recent publications written about "Coronary Artery Disease" by people in Profiles.
-
Park I, Watkins M, Dinh D, Brennan A, Batchelor RJ, Park J, Grbac A, Norman S, Walker M, Stub D, Reid CM, Biswas S, Lefkovits J, Taylor AJ, Koshy AN. Clinical Outcomes in Young Patients Undergoing Percutaneous Coronary Intervention. Catheter Cardiovasc Interv. 2026 Apr; 107(5):1303-1311.
-
Watkins M, Park J, Dinh D, Brennan A, Batchelor R, Stub D, Reid C, Koshy AN, Lefkovits J, Taylor AJ, Biswas S. Prevalence, Predictors and Clinical Outcomes of Percutaneous Coronary Intervention For In-Stent Restenosis versus De Novo Coronary Artery Disease. Am J Cardiol. 2026 Mar 01; 262:45-51.
-
Cuenza L, Honda S, Fong KY, Sawano M, Cader FA, Surunchupakorn P, Widodo WA, Dalakoti M, Kang J, Chimura M, Al-Omary M, Lee ZV, Sari NY, Suesat T, Ahmad T, Magno JD, Tan CT, Tiksnadi BB, Hewarathna U, Habib F, Lee DPH, Yap J. Variations in management strategies for stable coronary artery disease in the Asia-Pacific region: Insights from a multinational survey. Ann Acad Med Singap. 2025 May 22; 54(5):283-295.
-
Ren J, Bloom JE, Chan W, Reid CM, Smith JA, Taylor A, Kaye D, Royse C, Tian DH, Bowyer A, El-Ansary D, Royse A. Survival Outcomes After Multiple vs Single Arterial Grafting Among Patients With Reduced Ejection Fraction. JAMA Netw Open. 2025 04 01; 8(4):e254508.
-
Kim H, Park YM, Ko SH, Cho YJ, Kim HW, Kim YK, Han KD, Yun JS, Kim K, Moon D. Blood pressure levels and risk of end-stage renal disease in patients with type 2 diabetes who underwent percutaneous coronary intervention: a nationwide population-based study. Sci Rep. 2025 Mar 06; 15(1):7832.
-
Loh EW, Huang W, Sultana R, Kong SC, Ng CJ, Tan SY, Chin C, Yap JJL, Yeo KK. Association of blood pressure and left ventricular mass with subclinical coronary atherosclerosis. Open Heart. 2025 Feb 11; 12(1).
-
Liang J, Hussainy S, Lee SM, Wu G, Bautista N, Ding M, Wang H, LaFleur B, Perry G, Wang X. Association of Polygenic Risk Score for 5 Diseases With Alzheimer Disease Progression, Biomarkers, and Amyloid Deposition. Neurology. 2025 Feb 25; 104(4):e210250.
-
Kessler Iglesias C, Bloom JE, Xiao X, Moskovitch J, Eckford H, Offen S, Kotlyar E, Keogh A, Jabbour A, Bergin P, Leet A, Hare JL, Taylor AJ, Hayward CS, Jansz P, Kaye DM, Macdonald PS, Muthiah K. Early Use of Aspirin for Coronary Allograft Prophylaxis in Heart Transplant Recipients. Transplantation. 2025 02 01; 109(2):346-351.
-
Freeman ML, Hossain MB, Burrowes SAB, Jeudy J, Diaz-Mendez F, Mitchell SE, Prabhu SD, Lederman MM, Bagchi S. Association of T-Cell Phenotypes With Peri-Coronary Inflammation in People With and Without HIV and Without Cardiovascular Disease. Circ Cardiovasc Imaging. 2025 Jan; 18(1):e017033.
-
Chen R, Morris BJ, Donlon TA, Nakagawa K, Allsopp RC, Willcox BJ, Masaki KH. FOXO3 Longevity Genotype Mitigates Risk Posed by Hypertension on Incident Coronary Artery Disease in Middle-Aged Men: Kuakini Honolulu Heart Program. J Gerontol A Biol Sci Med Sci. 2024 12 01; 79(12).